Literature DB >> 23215823

A dedicated GvHD clinic may improve the quality of life for allogeneic stem cell transplant survivors.

F L Dignan, R Manwani, M N Potter, M E Ethell, H Leonard, J Brennan, J Baker, B E Shaw.   

Abstract

Mesh：

Year:  2012        PMID： 23215823     DOI： 10.1111/ctr.12051

Source DB:  PubMed          Journal:  Clin Transplant        ISSN： 0902-0063            Impact factor:   2.863


× No keyword cloud information.
  2 in total

Review 1.  New perspectives on the use of mTOR inhibitors in allogeneic haematopoietic stem cell transplantation and graft-versus-host disease.

Authors:  Mathias Lutz; Stephan Mielke
Journal:  Br J Clin Pharmacol       Date:  2016-06-22       Impact factor: 4.335

2.  Which questionnaires should we use to evaluate quality of life in patients with chronic graft-vs-host disease?

Authors:  Zinaida Perić; Lana Desnica; Nadira Duraković; Alen Ostojić; Dražen Pulanić; Ranka Serventi-Seiwerth; Ema Prenc; Grzegorz Basak; Radovan Vrhovac; Steven Z Pavletic; Damir Nemet
Journal:  Croat Med J       Date:  2016-02       Impact factor: 1.351
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.